Clinical Trial Update: Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

View source ↗

Summary

A long-term extension study of Miravirsen in genotype 1 chronic hepatitis C patients who did not respond to pegylated interferon alfa plus ribavirin has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Miravirsen (miravirsen)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Hepatitis C | Status: COMPLETED